We are live on ! Find out more
Amundi

Amundi Portfolio holdings

AUM $367B
1-Year Est. Return 31.23%
 

Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.

This Fund
S&P 500
This Quarter Est. Return
+12.77%
1 Year Est. Return
+31.23%
3 Year Est. Return
+96.94%
5 Year Est. Return
+128.55%
10 Year Est. Return
AUM
$222B
AUM Growth
+$18.7B
Cap. Flow
-$2.9B
Cap. Flow %
-1.31%
Top 10 Hldgs %
22.68%
Holding
2,118
New
107
Increased
857
Reduced
762
Closed
120

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$398M
2
AAPL icon
Apple
AAPL
+$326M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$286M
4
UNH icon
UnitedHealth
UNH
+$267M
5
VLTO icon
Veralto
VLTO
+$265M

Sector Composition

Rank Sector Weight
1 Technology 29%
2 Healthcare 13.85%
3 Consumer Discretionary 11.46%
4 Financials 11.04%
5 Industrials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITOS
1926
DELISTED
iTeos Therapeutics
ITOS
-1,799
Closed -$16.3K
KNSA icon
1927
Kiniksa Pharmaceuticals
KNSA
$4.83B
-5,770
Closed -$94.1K
KNSL icon
1928
Kinsale Capital Group
KNSL
$7.95B
-11
Closed -$4.83K
KYMR icon
1929
Kymera Therapeutics
KYMR
$9.1B
-1,642
Closed -$20.7K
LFST icon
1930
Lifestance Health
LFST
$4.16B
-2,323
Closed -$14.3K
LOPE icon
1931
Grand Canyon Education
LOPE
$3.71B
-13,606
Closed -$1.58M
LPRO
1932
Open Lending Corp
LPRO
$373M
-49,661
Closed -$324K
LPSN icon
1933
LivePerson
LPSN
$18.9M
-2,156
Closed -$90.2K
LUNG icon
1934
Pulmonx
LUNG
$49.4M
-26,586
Closed -$212K
MAXN
1935
DELISTED
Maxeon Solar Technologies
MAXN
-1,126
Closed -$1.02M
MIDD icon
1936
Middleby
MIDD
$6.05B
-146,441
Closed -$17.5M
MNTK icon
1937
Montauk Renewables
MNTK
$266M
-90,474
Closed -$916K
CALY
1938
Callaway Golf Company
CALY
$3.26B
-1,707,843
Closed -$21.6M
MOG.A icon
1939
Moog Inc Class A
MOG.A
$13B
-21,000
Closed -$2.41M
MRTN icon
1940
Marten Transport
MRTN
$1.33B
-863
Closed -$17K
MVIS icon
1941
Microvision
MVIS
$88.2M
-156,367
Closed -$324K
NCNO icon
1942
nCino
NCNO
$1.81B
-3,664
Closed -$103K
NEU icon
1943
NewMarket
NEU
$7.17B
-3,114
Closed -$1.41M
NIO icon
1944
NIO
NIO
$11.3B
-783,000
Closed -$7.07M
NOV icon
1945
NOV
NOV
$7.45B
-109,952
Closed -$2.25M
OGE icon
1946
OGE Energy
OGE
$10.3B
-118
Closed -$4.03K
OM icon
1947
Outset Medical
OM
$74.9M
-7,818
Closed -$398K
OPEN icon
1948
Opendoor
OPEN
$3.7B
-194,081
Closed -$453K
OSPN icon
1949
OneSpan
OSPN
$562M
-32,257
Closed -$291K
PARAA
1950
DELISTED
Paramount Global Class A
PARAA
-12
Closed -$179

Similar funds

Amundi's Q4 2023 Portfolio in Review

As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
  • Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
  • Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
  • Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
  • Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
  • Amundi opened 107 new positions and closed 120 in Q4 2023.
  • Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.

Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.